nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—PTGS1—Ifosfamide—testicular cancer	0.089	0.145	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—testicular cancer	0.058	0.0946	CbGbCtD
Acetylsalicylic acid—CYP2C8—Ifosfamide—testicular cancer	0.0514	0.0838	CbGbCtD
Acetylsalicylic acid—PTGS2—Cisplatin—testicular cancer	0.0513	0.0837	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—testicular cancer	0.0504	0.0822	CbGbCtD
Acetylsalicylic acid—CYP2C19—Ifosfamide—testicular cancer	0.0431	0.0703	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—testicular cancer	0.0425	0.0694	CbGbCtD
Acetylsalicylic acid—CYP2C9—Ifosfamide—testicular cancer	0.0358	0.0585	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—testicular cancer	0.0295	0.0481	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—testicular cancer	0.0246	0.0402	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—testicular cancer	0.0246	0.0401	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—testicular cancer	0.021	0.0343	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinblastine—testicular cancer	0.0184	0.0301	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cisplatin—testicular cancer	0.0174	0.0284	CbGbCtD
Acetylsalicylic acid—ABCB1—Cisplatin—testicular cancer	0.0169	0.0276	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—testicular cancer	0.0166	0.0271	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—testicular cancer	0.0113	0.0185	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—testicular cancer	0.011	0.0179	CbGbCtD
Acetylsalicylic acid—TP53—embryo—testicular cancer	0.00607	0.0519	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—testicular cancer	0.00597	0.0511	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—testicular cancer	0.00585	0.0501	CbGeAlD
Acetylsalicylic acid—NFKBIA—seminal vesicle—testicular cancer	0.00561	0.048	CbGeAlD
Acetylsalicylic acid—HSPA5—seminal vesicle—testicular cancer	0.0055	0.047	CbGeAlD
Acetylsalicylic acid—NFKBIA—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.00524	0.0428	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.00524	0.0428	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—embryo—testicular cancer	0.00498	0.0426	CbGeAlD
Acetylsalicylic acid—RPS6KA3—seminal vesicle—testicular cancer	0.00468	0.04	CbGeAlD
Acetylsalicylic acid—TP53—gonad—testicular cancer	0.00412	0.0353	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—testicular cancer	0.00405	0.0347	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—testicular cancer	0.00397	0.034	CbGeAlD
Acetylsalicylic acid—EDNRA—seminal vesicle—testicular cancer	0.00381	0.0326	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—testicular cancer	0.00368	0.0315	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—testicular cancer	0.00335	0.0287	CbGeAlD
Acetylsalicylic acid—NFKBIA—Downstream TCR signaling—BCL10—testicular cancer	0.0033	0.027	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—female gonad—testicular cancer	0.0033	0.0282	CbGeAlD
Acetylsalicylic acid—HSPA5—female gonad—testicular cancer	0.00323	0.0276	CbGeAlD
Acetylsalicylic acid—IKBKB—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.00318	0.026	CbGpPWpGaD
Acetylsalicylic acid—TP53—testis—testicular cancer	0.00297	0.0254	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—testicular cancer	0.00292	0.025	CbGeAlD
Acetylsalicylic acid—HSPA5—testis—testicular cancer	0.00286	0.0245	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female gonad—testicular cancer	0.00275	0.0235	CbGeAlD
Acetylsalicylic acid—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00264	0.0216	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00256	0.0209	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—gonad—testicular cancer	0.0025	0.0214	CbGeAlD
Acetylsalicylic acid—NFKBIA—TCR signaling—BCL10—testicular cancer	0.00247	0.0202	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—testis—testicular cancer	0.00244	0.0209	CbGeAlD
Acetylsalicylic acid—IKBKB—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.00233	0.019	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.00233	0.019	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00228	0.0187	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—female gonad—testicular cancer	0.00223	0.0191	CbGeAlD
Acetylsalicylic acid—NFKBIA—BCR signaling pathway—BCL10—testicular cancer	0.00223	0.0182	CbGpPWpGaD
Acetylsalicylic acid—TP53—lymph node—testicular cancer	0.00215	0.0184	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—testicular cancer	0.00212	0.0181	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—testicular cancer	0.00207	0.0177	CbGeAlD
Acetylsalicylic acid—TP53—LKB1 signaling events—STK11—testicular cancer	0.00205	0.0167	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00203	0.0166	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—female gonad—testicular cancer	0.00203	0.0174	CbGeAlD
Acetylsalicylic acid—EDNRA—testis—testicular cancer	0.00198	0.017	CbGeAlD
Acetylsalicylic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00185	0.0151	CbGpPWpGaD
Acetylsalicylic acid—TP53—Bladder Cancer—FGFR3—testicular cancer	0.00183	0.0149	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—testis—testicular cancer	0.0018	0.0154	CbGeAlD
Acetylsalicylic acid—EDNRA—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00177	0.0145	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—lymph node—testicular cancer	0.00177	0.0151	CbGeAlD
Acetylsalicylic acid—NFKBIA—TCR Signaling Pathway—BCL10—testicular cancer	0.00176	0.0144	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—testis—testicular cancer	0.00175	0.0149	CbGeAlD
Acetylsalicylic acid—NFKBIA—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.00166	0.0135	CbGpPWpGaD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—testicular cancer	0.00156	0.18	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Osteopontin-mediated events—MMP2—testicular cancer	0.0015	0.0123	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—MAD1L1—testicular cancer	0.00148	0.0121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream TCR signaling—BCL10—testicular cancer	0.00147	0.012	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—lymph node—testicular cancer	0.00144	0.0123	CbGeAlD
Acetylsalicylic acid—TP53—AMPK Signaling—STK11—testicular cancer	0.0014	0.0115	CbGpPWpGaD
Acetylsalicylic acid—TP53—Vincristine—Vinblastine—testicular cancer	0.00134	0.154	CbGdCrCtD
Acetylsalicylic acid—RPS6KA3—Kit receptor signaling pathway—KITLG—testicular cancer	0.00133	0.0109	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle Checkpoints—MAD1L1—testicular cancer	0.00133	0.0108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—lymph node—testicular cancer	0.0013	0.0112	CbGeAlD
Acetylsalicylic acid—TP53—DNA Damage/Telomere Stress Induced Senescence—H2AFZ—testicular cancer	0.0013	0.0107	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—PRDM14—testicular cancer	0.00122	0.00998	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0012	0.0098	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00119	0.00976	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00119	0.00971	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—testicular cancer	0.00118	0.137	CbGdCrCtD
Acetylsalicylic acid—TP53—Retinoblastoma (RB) in Cancer—H2AFZ—testicular cancer	0.00117	0.00957	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—embryo—testicular cancer	0.00117	0.01	CbGeAlD
Acetylsalicylic acid—PTGS1—seminal vesicle—testicular cancer	0.00115	0.00983	CbGeAlD
Acetylsalicylic acid—PTGS2—seminal vesicle—testicular cancer	0.0011	0.0094	CbGeAlD
Acetylsalicylic acid—IKBKB—TCR signaling—BCL10—testicular cancer	0.0011	0.00896	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00107	0.00877	CbGpPWpGaD
Acetylsalicylic acid—ALB—testis—testicular cancer	0.00105	0.00899	CbGeAlD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.00102	0.00837	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00101	0.00829	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinblastine—testicular cancer	0.00101	0.117	CbGdCrCtD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.001	0.00819	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BCR signaling pathway—BCL10—testicular cancer	0.00099	0.0081	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—KITLG—testicular cancer	0.000948	0.00775	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—B Cell Activation—BCL10—testicular cancer	0.000947	0.00775	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000924	0.00755	CbGpPWpGaD
Acetylsalicylic acid—TP53—Oxidative Stress Induced Senescence—H2AFZ—testicular cancer	0.000911	0.00745	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.000911	0.00745	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Kit receptor signaling pathway—KIT—testicular cancer	0.000907	0.00741	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—INSL3—testicular cancer	0.000904	0.0074	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000864	0.00706	CbGpPWpGaD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000854	0.00698	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—LPA receptor mediated events—MMP2—testicular cancer	0.000842	0.00689	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000841	0.00687	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—AGE/RAGE pathway—MMP2—testicular cancer	0.000822	0.00672	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000784	0.00641	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—BCL10—testicular cancer	0.000782	0.00639	CbGpPWpGaD
Acetylsalicylic acid—ALB—lymph node—testicular cancer	0.000762	0.00651	CbGeAlD
Acetylsalicylic acid—TP53—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.000749	0.00612	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—testis—testicular cancer	0.000738	0.00632	CbGeAlD
Acetylsalicylic acid—IKBKB—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.000736	0.00602	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000733	0.00599	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—embryo—testicular cancer	0.000724	0.00619	CbGeAlD
Acetylsalicylic acid—ABCB1—seminal vesicle—testicular cancer	0.00068	0.00581	CbGeAlD
Acetylsalicylic acid—PTGS1—female gonad—testicular cancer	0.000675	0.00577	CbGeAlD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—BCL10—testicular cancer	0.000665	0.00544	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000647	0.00529	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—female gonad—testicular cancer	0.000645	0.00552	CbGeAlD
Acetylsalicylic acid—Anaemia—Vinblastine—testicular cancer	0.000639	0.00459	CcSEcCtD
Acetylsalicylic acid—TP53—Cellular Senescence—H2AFZ—testicular cancer	0.000638	0.00521	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000628	0.00513	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Bleomycin—testicular cancer	0.000622	0.00447	CcSEcCtD
Acetylsalicylic acid—Vertigo—Vinblastine—testicular cancer	0.000621	0.00446	CcSEcCtD
Acetylsalicylic acid—Confusional state—Chlorambucil—testicular cancer	0.000621	0.00446	CcSEcCtD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000621	0.00507	CbGpPWpGaD
Acetylsalicylic acid—Leukopenia—Vinblastine—testicular cancer	0.000619	0.00444	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—testicular cancer	0.000617	0.0713	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—testicular cancer	0.000617	0.0713	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—testicular cancer	0.000617	0.0713	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000617	0.00505	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000609	0.00498	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Chlorambucil—testicular cancer	0.000603	0.00433	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vinblastine—testicular cancer	0.000599	0.0043	CcSEcCtD
Acetylsalicylic acid—PTGS1—testis—testicular cancer	0.000599	0.00512	CbGeAlD
Acetylsalicylic acid—Hypertension—Vinblastine—testicular cancer	0.000597	0.00428	CcSEcCtD
Acetylsalicylic acid—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000597	0.00488	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Dactinomycin—testicular cancer	0.00058	0.00417	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—H2AFZ—testicular cancer	0.000577	0.00471	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Ifosfamide—testicular cancer	0.000576	0.00414	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Ifosfamide—testicular cancer	0.000573	0.00412	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—testicular cancer	0.000571	0.066	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—testicular cancer	0.000571	0.066	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—testicular cancer	0.000571	0.066	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—B Cell Activation—KITLG—testicular cancer	0.000571	0.00467	CbGpPWpGaD
Acetylsalicylic acid—Ulcer—Methotrexate—testicular cancer	0.000571	0.0041	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vinblastine—testicular cancer	0.000552	0.00397	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Methotrexate—testicular cancer	0.00055	0.00395	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Chlorambucil—testicular cancer	0.000542	0.00389	CcSEcCtD
Acetylsalicylic acid—Anaemia—Bleomycin—testicular cancer	0.00054	0.00387	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Ifosfamide—testicular cancer	0.000534	0.00384	CcSEcCtD
Acetylsalicylic acid—Ulcer—Epirubicin—testicular cancer	0.000534	0.00384	CcSEcCtD
Acetylsalicylic acid—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000532	0.00435	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Ifosfamide—testicular cancer	0.000532	0.00382	CcSEcCtD
Acetylsalicylic acid—Melaena—Methotrexate—testicular cancer	0.000527	0.00379	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Bleomycin—testicular cancer	0.000523	0.00375	CcSEcCtD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—INSL3—testicular cancer	0.000511	0.00418	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000507	0.00415	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Chlorambucil—testicular cancer	0.000507	0.00364	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—testicular cancer	0.000505	0.00363	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—testicular cancer	0.000503	0.00361	CcSEcCtD
Acetylsalicylic acid—Chest pain—Bleomycin—testicular cancer	0.000497	0.00357	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—testicular cancer	0.000494	0.00355	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—testicular cancer	0.000494	0.00354	CcSEcCtD
Acetylsalicylic acid—Coma—Methotrexate—testicular cancer	0.000493	0.00354	CcSEcCtD
Acetylsalicylic acid—ABCB1—gonad—testicular cancer	0.000491	0.0042	CbGeAlD
Acetylsalicylic acid—Urticaria—Chlorambucil—testicular cancer	0.000489	0.00351	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000489	0.004	CbGpPWpGaD
Acetylsalicylic acid—Leukopenia—Dactinomycin—testicular cancer	0.000487	0.0035	CcSEcCtD
Acetylsalicylic acid—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000486	0.00397	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—H2AFZ—testicular cancer	0.000482	0.00394	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000481	0.00393	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Bleomycin—testicular cancer	0.00048	0.00345	CcSEcCtD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.000477	0.0039	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Bleomycin—testicular cancer	0.000476	0.00342	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—testicular cancer	0.000468	0.00336	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Bleomycin—testicular cancer	0.000466	0.00335	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Vinblastine—testicular cancer	0.000465	0.00334	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—INSL3—testicular cancer	0.000464	0.0038	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—INSL3—testicular cancer	0.000464	0.0038	CbGpPWpGaD
Acetylsalicylic acid—Coma—Epirubicin—testicular cancer	0.000462	0.00332	CcSEcCtD
Acetylsalicylic acid—Anaemia—Ifosfamide—testicular cancer	0.000461	0.00331	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Cisplatin—testicular cancer	0.000461	0.00331	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000459	0.00375	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Cisplatin—testicular cancer	0.000459	0.00329	CcSEcCtD
Acetylsalicylic acid—Agitation—Ifosfamide—testicular cancer	0.000458	0.00329	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—testicular cancer	0.000457	0.00328	CcSEcCtD
Acetylsalicylic acid—Angioedema—Ifosfamide—testicular cancer	0.000456	0.00327	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000455	0.00372	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Chlorambucil—testicular cancer	0.000454	0.00326	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000451	0.00368	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—testicular cancer	0.000451	0.00324	CcSEcCtD
Acetylsalicylic acid—Vertigo—Ifosfamide—testicular cancer	0.000448	0.00322	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Ifosfamide—testicular cancer	0.000447	0.00321	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—testicular cancer	0.000446	0.0032	CcSEcCtD
Acetylsalicylic acid—TP53—Direct p53 effectors—MMP2—testicular cancer	0.000445	0.00364	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000441	0.00361	CbGpPWpGaD
Acetylsalicylic acid—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000437	0.00357	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—H2AFZ—testicular cancer	0.000436	0.00356	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Chlorambucil—testicular cancer	0.000436	0.00313	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—testicular cancer	0.000435	0.00312	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—testicular cancer	0.000434	0.00371	CbGeAlD
Acetylsalicylic acid—Convulsion—Ifosfamide—testicular cancer	0.000432	0.0031	CcSEcCtD
Acetylsalicylic acid—Hypertension—Ifosfamide—testicular cancer	0.000431	0.00309	CcSEcCtD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000427	0.00349	CbGpPWpGaD
Acetylsalicylic acid—Coma—Doxorubicin—testicular cancer	0.000427	0.00307	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Bleomycin—testicular cancer	0.000425	0.00305	CcSEcCtD
Acetylsalicylic acid—Chest pain—Ifosfamide—testicular cancer	0.000425	0.00305	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Ifosfamide—testicular cancer	0.000425	0.00305	CcSEcCtD
Acetylsalicylic acid—NFKBIA—B Cell Activation—FGFR3—testicular cancer	0.000425	0.00347	CbGpPWpGaD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—testicular cancer	0.000422	0.00303	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000421	0.00344	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—BCL10—testicular cancer	0.000421	0.00344	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Chlorambucil—testicular cancer	0.000421	0.00302	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—KITLG—testicular cancer	0.000421	0.00344	CbGpPWpGaD
Acetylsalicylic acid—Flushing—Etoposide—testicular cancer	0.00042	0.00302	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vinblastine—testicular cancer	0.000416	0.00298	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—testicular cancer	0.000415	0.00355	CbGeAlD
Acetylsalicylic acid—Confusional state—Ifosfamide—testicular cancer	0.000411	0.00295	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Epirubicin—testicular cancer	0.00041	0.00294	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Ifosfamide—testicular cancer	0.000407	0.00292	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—BCL10—testicular cancer	0.000403	0.0033	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—KITLG—testicular cancer	0.000401	0.00328	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—female gonad—testicular cancer	0.000399	0.00341	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Ifosfamide—testicular cancer	0.000399	0.00286	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—BCL10—testicular cancer	0.000398	0.00325	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Cisplatin—testicular cancer	0.000398	0.00285	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Ifosfamide—testicular cancer	0.000394	0.00283	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Bleomycin—testicular cancer	0.000393	0.00282	CcSEcCtD
Acetylsalicylic acid—Vomiting—Chlorambucil—testicular cancer	0.000391	0.00281	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—testicular cancer	0.00039	0.0028	CcSEcCtD
Acetylsalicylic acid—NFKBIA—B Cell Activation—KIT—testicular cancer	0.00039	0.00319	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cell Cycle—MAD1L1—testicular cancer	0.000388	0.00317	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Vinblastine—testicular cancer	0.000386	0.00277	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—testicular cancer	0.000385	0.00277	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Cisplatin—testicular cancer	0.000385	0.00276	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—INSL3—testicular cancer	0.000383	0.00313	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—BCL10—testicular cancer	0.000382	0.00312	CbGpPWpGaD
Acetylsalicylic acid—Purpura—Epirubicin—testicular cancer	0.000381	0.00273	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—testicular cancer	0.000379	0.00272	CcSEcCtD
Acetylsalicylic acid—Urticaria—Bleomycin—testicular cancer	0.000378	0.00272	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—KITLG—testicular cancer	0.000376	0.00307	CbGpPWpGaD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—testicular cancer	0.000376	0.0027	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinblastine—testicular cancer	0.000373	0.00268	CcSEcCtD
Acetylsalicylic acid—Convulsion—Cisplatin—testicular cancer	0.000373	0.00268	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000367	0.00263	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—testicular cancer	0.000366	0.00263	CcSEcCtD
Acetylsalicylic acid—Nausea—Chlorambucil—testicular cancer	0.000366	0.00263	CcSEcCtD
Acetylsalicylic acid—IKBKB—AGE/RAGE pathway—MMP2—testicular cancer	0.000365	0.00299	CbGpPWpGaD
Acetylsalicylic acid—Anaemia—Etoposide—testicular cancer	0.000364	0.00261	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000363	0.00297	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Ifosfamide—testicular cancer	0.000363	0.00261	CcSEcCtD
Acetylsalicylic acid—Somnolence—Ifosfamide—testicular cancer	0.000362	0.0026	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vinblastine—testicular cancer	0.000359	0.00258	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—testicular cancer	0.000357	0.00256	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—BCL10—testicular cancer	0.000356	0.00291	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Etoposide—testicular cancer	0.000354	0.00254	CcSEcCtD
Acetylsalicylic acid—ABCB1—testis—testicular cancer	0.000354	0.00303	CbGeAlD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000354	0.00289	CbGpPWpGaD
Acetylsalicylic acid—Leukopenia—Etoposide—testicular cancer	0.000353	0.00253	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—testicular cancer	0.000352	0.00253	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Cisplatin—testicular cancer	0.000351	0.00252	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Bleomycin—testicular cancer	0.000351	0.00252	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—testicular cancer	0.000348	0.0025	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—testicular cancer	0.000346	0.00249	CcSEcCtD
Acetylsalicylic acid—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000344	0.00281	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Cisplatin—testicular cancer	0.000344	0.00247	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Cisplatin—testicular cancer	0.000343	0.00246	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—testicular cancer	0.000341	0.00245	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—testicular cancer	0.00034	0.00244	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000339	0.00244	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cisplatin—testicular cancer	0.000339	0.00244	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—testicular cancer	0.000339	0.00243	CcSEcCtD
Acetylsalicylic acid—Pruritus—Bleomycin—testicular cancer	0.000337	0.00242	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Ifosfamide—testicular cancer	0.000336	0.00241	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—testicular cancer	0.000335	0.00241	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinblastine—testicular cancer	0.000335	0.00241	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—testicular cancer	0.000334	0.0024	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000334	0.00273	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—testicular cancer	0.000327	0.00235	CcSEcCtD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000325	0.00266	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Etoposide—testicular cancer	0.000324	0.00233	CcSEcCtD
Acetylsalicylic acid—Urticaria—Ifosfamide—testicular cancer	0.000323	0.00232	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—testicular cancer	0.000322	0.00231	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—testicular cancer	0.000317	0.00228	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—testicular cancer	0.000317	0.00228	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—testicular cancer	0.000315	0.00226	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—testicular cancer	0.000314	0.00225	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cisplatin—testicular cancer	0.000313	0.00225	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—FGFR3—testicular cancer	0.000313	0.00256	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—testicular cancer	0.000311	0.00223	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—testicular cancer	0.000309	0.00222	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—INSL3—testicular cancer	0.000307	0.00251	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—testicular cancer	0.000304	0.00218	CcSEcCtD
Acetylsalicylic acid—TP53—Signaling Pathways—INSL3—testicular cancer	0.000303	0.00248	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Bleomycin—testicular cancer	0.000303	0.00218	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—testicular cancer	0.000302	0.00217	CcSEcCtD
Acetylsalicylic acid—Rash—Bleomycin—testicular cancer	0.0003	0.00216	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Bleomycin—testicular cancer	0.0003	0.00215	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Ifosfamide—testicular cancer	0.0003	0.00215	CcSEcCtD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—FGFR3—testicular cancer	0.000298	0.00244	CbGpPWpGaD
Acetylsalicylic acid—Asthma—Doxorubicin—testicular cancer	0.000293	0.00211	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—testicular cancer	0.000293	0.00211	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—testicular cancer	0.00029	0.00208	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Cisplatin—testicular cancer	0.000289	0.00208	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ifosfamide—testicular cancer	0.000288	0.00207	CcSEcCtD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000288	0.00235	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—KIT—testicular cancer	0.000287	0.00235	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Etoposide—testicular cancer	0.000287	0.00206	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—testicular cancer	0.000286	0.00205	CcSEcCtD
Acetylsalicylic acid—Nausea—Bleomycin—testicular cancer	0.000283	0.00203	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—testicular cancer	0.000283	0.00203	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—testicular cancer	0.000283	0.00203	CcSEcCtD
Acetylsalicylic acid—Rash—Dactinomycin—testicular cancer	0.00028	0.00201	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—FGFR3—testicular cancer	0.000279	0.00228	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Ifosfamide—testicular cancer	0.000279	0.002	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000274	0.00224	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—INSL3—testicular cancer	0.000274	0.00224	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—INSL3—testicular cancer	0.000274	0.00224	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—KIT—testicular cancer	0.000274	0.00224	CbGpPWpGaD
Acetylsalicylic acid—Haemoglobin—Methotrexate—testicular cancer	0.000273	0.00196	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—testicular cancer	0.000271	0.00195	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—testicular cancer	0.000271	0.00195	CcSEcCtD
Acetylsalicylic acid—TP53—Cell Cycle—H2AFZ—testicular cancer	0.00027	0.00221	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Ifosfamide—testicular cancer	0.000269	0.00193	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—testicular cancer	0.000265	0.0019	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—testicular cancer	0.000264	0.0019	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—testicular cancer	0.000262	0.00188	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ifosfamide—testicular cancer	0.000259	0.00186	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cisplatin—testicular cancer	0.000259	0.00186	CcSEcCtD
Acetylsalicylic acid—Rash—Ifosfamide—testicular cancer	0.000257	0.00184	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—testicular cancer	0.000257	0.00219	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—KIT—testicular cancer	0.000257	0.0021	CbGpPWpGaD
Acetylsalicylic acid—Dermatitis—Ifosfamide—testicular cancer	0.000256	0.00184	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—testicular cancer	0.000255	0.00183	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—testicular cancer	0.000255	0.00183	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—KITLG—testicular cancer	0.000254	0.00208	CbGpPWpGaD
Acetylsalicylic acid—Haemorrhage—Epirubicin—testicular cancer	0.000254	0.00182	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—testicular cancer	0.000253	0.00182	CcSEcCtD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000251	0.00205	CbGpPWpGaD
Acetylsalicylic acid—Sweating—Doxorubicin—testicular cancer	0.000251	0.0018	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—KITLG—testicular cancer	0.000243	0.00199	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000242	0.00198	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Ifosfamide—testicular cancer	0.000242	0.00174	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cisplatin—testicular cancer	0.00024	0.00172	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KITLG—testicular cancer	0.00024	0.00196	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Etoposide—testicular cancer	0.000237	0.0017	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—testicular cancer	0.000237	0.0017	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—testicular cancer	0.000236	0.00169	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—testicular cancer	0.000235	0.00169	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—testicular cancer	0.000235	0.00169	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—BCL10—testicular cancer	0.000232	0.00189	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KITLG—testicular cancer	0.00023	0.00188	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Etoposide—testicular cancer	0.000228	0.00163	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cisplatin—testicular cancer	0.000223	0.0016	CcSEcCtD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000222	0.00182	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000222	0.00182	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Biological oxidations—HPGDS—testicular cancer	0.000222	0.00182	CbGpPWpGaD
Acetylsalicylic acid—Rash—Cisplatin—testicular cancer	0.000221	0.00159	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cisplatin—testicular cancer	0.000221	0.00159	CcSEcCtD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—MMP2—testicular cancer	0.000221	0.0018	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Etoposide—testicular cancer	0.00022	0.00158	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—testicular cancer	0.000219	0.00157	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—testicular cancer	0.000218	0.00157	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—testicular cancer	0.000218	0.00156	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KITLG—testicular cancer	0.000214	0.00175	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000214	0.00175	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Etoposide—testicular cancer	0.000213	0.00153	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—testicular cancer	0.000212	0.00152	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—testicular cancer	0.000211	0.00152	CcSEcCtD
Acetylsalicylic acid—Nausea—Cisplatin—testicular cancer	0.000209	0.0015	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—BCL10—testicular cancer	0.000207	0.00169	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—MMP2—testicular cancer	0.000206	0.00168	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Methotrexate—testicular cancer	0.000204	0.00147	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—testicular cancer	0.000204	0.00147	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—testicular cancer	0.000204	0.00147	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000204	0.00167	CbGpPWpGaD
Acetylsalicylic acid—Agitation—Epirubicin—testicular cancer	0.000203	0.00146	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—testicular cancer	0.000203	0.00146	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—testicular cancer	0.000203	0.00145	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—testicular cancer	0.000201	0.00144	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—testicular cancer	0.000201	0.00144	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Metabolism—HPGDS—testicular cancer	0.000201	0.00164	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Epirubicin—testicular cancer	0.000198	0.00142	CcSEcCtD
Acetylsalicylic acid—CYP2C19—Biological oxidations—HPGDS—testicular cancer	0.000198	0.00162	CbGpPWpGaD
Acetylsalicylic acid—Syncope—Epirubicin—testicular cancer	0.000198	0.00142	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—testicular cancer	0.000198	0.00142	CcSEcCtD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000196	0.0016	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000195	0.00159	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methotrexate—testicular cancer	0.000194	0.00139	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—testicular cancer	0.000194	0.00139	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—testicular cancer	0.000193	0.00138	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—testicular cancer	0.000191	0.00137	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—testicular cancer	0.000191	0.00137	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—testicular cancer	0.000191	0.00137	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—testicular cancer	0.000189	0.00136	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—FGFR3—testicular cancer	0.000189	0.00154	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—testicular cancer	0.000189	0.00135	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—testicular cancer	0.000188	0.00135	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—testicular cancer	0.000188	0.00135	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—testicular cancer	0.000188	0.00135	CcSEcCtD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000187	0.00153	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KITLG—testicular cancer	0.000187	0.00153	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—testicular cancer	0.000186	0.00134	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—testicular cancer	0.000184	0.00132	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—testicular cancer	0.000183	0.00132	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—testicular cancer	0.000183	0.00131	CcSEcCtD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000182	0.00149	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Epirubicin—testicular cancer	0.000182	0.00131	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—FGFR3—testicular cancer	0.000181	0.00148	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000181	0.00148	CbGpPWpGaD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—testicular cancer	0.00018	0.00129	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—testicular cancer	0.00018	0.00129	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—FGFR3—testicular cancer	0.000178	0.00146	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000178	0.00145	CbGpPWpGaD
Acetylsalicylic acid—Shock—Epirubicin—testicular cancer	0.000177	0.00127	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—testicular cancer	0.000177	0.00127	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—BCL10—testicular cancer	0.000177	0.00145	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—testicular cancer	0.000176	0.00127	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—testicular cancer	0.000176	0.00127	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—testicular cancer	0.000176	0.00126	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—H2AFZ—testicular cancer	0.000175	0.00143	CbGpPWpGaD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—testicular cancer	0.000174	0.00125	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—testicular cancer	0.000174	0.00125	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—testicular cancer	0.000174	0.00125	CcSEcCtD
Acetylsalicylic acid—IKBKB—B Cell Activation—KIT—testicular cancer	0.000173	0.00142	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Methotrexate—testicular cancer	0.000172	0.00123	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—testicular cancer	0.000171	0.00123	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—FGFR3—testicular cancer	0.000171	0.0014	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—BCL10—testicular cancer	0.00017	0.00139	CbGpPWpGaD
Acetylsalicylic acid—Dyspepsia—Methotrexate—testicular cancer	0.00017	0.00122	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—testicular cancer	0.000168	0.00121	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—testicular cancer	0.000167	0.0012	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—KIT—testicular cancer	0.000166	0.00136	CbGpPWpGaD
Acetylsalicylic acid—Shock—Doxorubicin—testicular cancer	0.000164	0.00118	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KIT—testicular cancer	0.000164	0.00134	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.000163	0.00117	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—testicular cancer	0.000163	0.00117	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—testicular cancer	0.000161	0.00116	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—KITLG—testicular cancer	0.000161	0.00132	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Epirubicin—testicular cancer	0.000161	0.00115	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—testicular cancer	0.00016	0.00115	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—FGFR3—testicular cancer	0.000159	0.0013	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—testicular cancer	0.000159	0.00114	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—testicular cancer	0.000159	0.00114	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KIT—testicular cancer	0.000157	0.00129	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Methotrexate—testicular cancer	0.000153	0.0011	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—testicular cancer	0.000149	0.00107	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—testicular cancer	0.000149	0.00107	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—testicular cancer	0.000148	0.00106	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—testicular cancer	0.000147	0.00105	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—MMP2—testicular cancer	0.000147	0.0012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KIT—testicular cancer	0.000146	0.0012	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—STK11—testicular cancer	0.000146	0.00119	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Epirubicin—testicular cancer	0.000143	0.00103	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—testicular cancer	0.000142	0.00102	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—KITLG—testicular cancer	0.00014	0.00114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—FGFR3—testicular cancer	0.000139	0.00114	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—testicular cancer	0.000137	0.000987	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INSL3—testicular cancer	0.000136	0.00111	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Methotrexate—testicular cancer	0.000136	0.000979	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—testicular cancer	0.000133	0.000954	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—testicular cancer	0.000133	0.000951	CcSEcCtD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000132	0.00108	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Methotrexate—testicular cancer	0.000132	0.000946	CcSEcCtD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000129	0.00106	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KIT—testicular cancer	0.000128	0.00104	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Epirubicin—testicular cancer	0.000128	0.000916	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—testicular cancer	0.000127	0.000915	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Immune System—KITLG—testicular cancer	0.000125	0.00102	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Epirubicin—testicular cancer	0.000123	0.000886	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—testicular cancer	0.000123	0.000882	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—H2AFZ—testicular cancer	0.000123	0.001	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Methotrexate—testicular cancer	0.000122	0.000879	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STK11—testicular cancer	0.000122	0.000997	CbGpPWpGaD
Acetylsalicylic acid—Rash—Methotrexate—testicular cancer	0.000121	0.000872	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—testicular cancer	0.000121	0.000871	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—FGFR3—testicular cancer	0.00012	0.000979	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Epirubicin—testicular cancer	0.000119	0.000856	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—testicular cancer	0.000118	0.000847	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—testicular cancer	0.000115	0.000823	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—testicular cancer	0.000114	0.000822	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—testicular cancer	0.000114	0.000819	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—testicular cancer	0.000114	0.000816	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—testicular cancer	0.000114	0.000815	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KITLG—testicular cancer	0.000113	0.000922	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Doxorubicin—testicular cancer	0.00011	0.000792	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—KIT—testicular cancer	0.00011	0.000899	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Epirubicin—testicular cancer	0.000107	0.000769	CcSEcCtD
Acetylsalicylic acid—IKBKB—Innate Immune System—KITLG—testicular cancer	0.000107	0.000872	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Doxorubicin—testicular cancer	0.000106	0.000761	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—testicular cancer	0.000105	0.000755	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—testicular cancer	0.000105	0.000754	CcSEcCtD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000105	0.000857	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—FGFR3—testicular cancer	0.000104	0.000849	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BCL10—testicular cancer	0.000103	0.000842	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KITLG—testicular cancer	0.000102	0.000837	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Doxorubicin—testicular cancer	9.91e-05	0.000711	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—H2AFZ—testicular cancer	9.82e-05	0.000803	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STK11—testicular cancer	9.76e-05	0.000798	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—H2AFZ—testicular cancer	9.71e-05	0.000794	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STK11—testicular cancer	9.65e-05	0.000789	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KIT—testicular cancer	9.53e-05	0.000779	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—FGFR3—testicular cancer	9.28e-05	0.000759	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KITLG—testicular cancer	9.03e-05	0.000739	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KITLG—testicular cancer	8.93e-05	0.00073	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—H2AFZ—testicular cancer	8.78e-05	0.000718	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—H2AFZ—testicular cancer	8.78e-05	0.000718	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STK11—testicular cancer	8.73e-05	0.000714	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STK11—testicular cancer	8.73e-05	0.000714	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.53e-05	0.000697	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KIT—testicular cancer	8.52e-05	0.000697	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.48e-05	0.000693	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—FGFR3—testicular cancer	8.38e-05	0.000686	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KITLG—testicular cancer	8.07e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KITLG—testicular cancer	8.07e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—FGFR3—testicular cancer	7.93e-05	0.000648	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KIT—testicular cancer	7.7e-05	0.000629	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—FGFR3—testicular cancer	7.61e-05	0.000622	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.61e-05	0.000622	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KIT—testicular cancer	7.28e-05	0.000595	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KIT—testicular cancer	6.99e-05	0.000571	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.94e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—FGFR3—testicular cancer	6.71e-05	0.000549	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—FGFR3—testicular cancer	6.64e-05	0.000543	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KITLG—testicular cancer	6.21e-05	0.000508	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KIT—testicular cancer	6.16e-05	0.000504	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KIT—testicular cancer	6.09e-05	0.000498	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FGFR3—testicular cancer	6e-05	0.000491	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FGFR3—testicular cancer	6e-05	0.000491	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HPGDS—testicular cancer	5.88e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KIT—testicular cancer	5.51e-05	0.00045	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KIT—testicular cancer	5.51e-05	0.00045	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HPGDS—testicular cancer	4.67e-05	0.000382	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FGFR3—testicular cancer	4.62e-05	0.000377	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—H2AFZ—testicular cancer	4.36e-05	0.000357	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STK11—testicular cancer	4.34e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—STK11—testicular cancer	4.27e-05	0.000349	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KIT—testicular cancer	4.24e-05	0.000347	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—H2AFZ—testicular cancer	4.07e-05	0.000333	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KITLG—testicular cancer	4.02e-05	0.000328	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HPGDS—testicular cancer	3.8e-05	0.00031	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HPGDS—testicular cancer	3.78e-05	0.000309	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KITLG—testicular cancer	3.75e-05	0.000306	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—STK11—testicular cancer	3.39e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HPGDS—testicular cancer	3.39e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HPGDS—testicular cancer	3.31e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HPGDS—testicular cancer	3.09e-05	0.000253	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGFR3—testicular cancer	2.98e-05	0.000244	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR3—testicular cancer	2.78e-05	0.000228	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—STK11—testicular cancer	2.76e-05	0.000226	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—STK11—testicular cancer	2.74e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—testicular cancer	2.74e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—testicular cancer	2.56e-05	0.000209	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—STK11—testicular cancer	2.46e-05	0.000201	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—STK11—testicular cancer	2.4e-05	0.000197	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—STK11—testicular cancer	2.25e-05	0.000184	CbGpPWpGaD
